Trial NCT02213744

View at ClinicalTrials.gov 
Org. Study IDs: MM-302-02-02-03

Last trial update was posted on 2017-01-06

MeSH Interventions

Capecitabine Gemcitabine Trastuzumab Vinorelbine

MeSH Conditions

Breast Neoplasms

Other Conditions

Breast Cancer HER2 Positive Breast Cancer

Stopping Reasons

Felt not to show benefit over control per DMC and confirmed via futility analysis

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID